GlaxoSmithKline

Do more, feel better, live longer
Advanced search

 

Flu information centre

This section provides pandemic flu information
and resources for the media, healthcare
professionals and the general public.

Man coughing

Thermometer showing high temperature

Lady sneezing



Q3 results 2009

Statement on Cervarix

Your GSK career

GSK worldwide


Our products

ViiV Healthcare - “The launch of ViiV Healthcare signifies a new approach to tackling HIV. Building on the strong heritage of GSK and Pfizer, to create a business that is progressive, sustainable and crucially, HIV patient-centric” - Andrew Witty, GSK CEO

A specialist HIV company with a sustainable commitment to delivering treatment and care, and improving access to medicines for people living with HIV


 

Corporate press releases

[an error occurred while processing this directive] [an error occurred while processing this directive]

06 November 2009
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine

03 November 2009
World’s largest malaria vaccine trial now underway in seven African countries

03 November 2009
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care

More press releases

RSS Subscribe to press release RSS feed
What are RSS feeds?

Investors

LSE
1219p
-1.00

7 Nov 2009 12:10pm GMT
NYSE
40.52
0.00

7 Nov 2009 closed
London Stock Exchange price updated every minute. Provided by
Hemscott Group Limited

Nurse and patient

Clinical trial data